FDA Inspection
Maxim Biomedical Inc.Maxim Biomedical Inc. – FDA Inspection, Jun 24, 2010
Record Details
This FDA Inspection record concerns Maxim Biomedical Inc., with an inspection on June 24, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Maxim Biomedical Inc.
- Inspection Date
- June 24, 2010
- Product Type
- Biologics
View Company Profile
ID · 5bac6a39-0d57-446e-9ad8-7ee14564fe52
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 684791
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Maxim Biomedical Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| May 7, 2025 | Not classified | Baltimore District Office | |
| November 2, 2023 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| February 7, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 18, 2018 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| May 18, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Maxim Biomedical Inc.
- FDA Inspection 1270828 - 2025-05-07
- FDA Inspection 1222136 - 2023-11-02
- FDA Inspection 1084838 - 2019-02-07
- FDA Inspection 1068675 - 2018-09-18
- FDA Inspection 1016285 - 2017-05-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.